Polynovo Ltd
ASX:PNV

Watchlist Manager
Polynovo Ltd Logo
Polynovo Ltd
ASX:PNV
Watchlist
Price: 1.98 AUD -0.5% Market Closed
Market Cap: 1.4B AUD
Have any thoughts about
Polynovo Ltd?
Write Note

Intrinsic Value

The intrinsic value of one PNV stock under the Base Case scenario is 0.81 AUD. Compared to the current market price of 1.98 AUD, Polynovo Ltd is Overvalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PNV Intrinsic Value
0.81 AUD
Overvaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Polynovo Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for PNV cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about PNV?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Polynovo Ltd

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Polynovo Ltd

Provide an overview of the primary business activities
of Polynovo Ltd.

What unique competitive advantages
does Polynovo Ltd hold over its rivals?

What risks and challenges
does Polynovo Ltd face in the near future?

Has there been any significant insider trading activity
in Polynovo Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Polynovo Ltd.

Provide P/S
for Polynovo Ltd.

Provide P/E
for Polynovo Ltd.

Provide P/OCF
for Polynovo Ltd.

Provide P/FCFE
for Polynovo Ltd.

Provide P/B
for Polynovo Ltd.

Provide EV/S
for Polynovo Ltd.

Provide EV/GP
for Polynovo Ltd.

Provide EV/EBITDA
for Polynovo Ltd.

Provide EV/EBIT
for Polynovo Ltd.

Provide EV/OCF
for Polynovo Ltd.

Provide EV/FCFF
for Polynovo Ltd.

Provide EV/IC
for Polynovo Ltd.

Show me price targets
for Polynovo Ltd made by professional analysts.

What are the Revenue projections
for Polynovo Ltd?

How accurate were the past Revenue estimates
for Polynovo Ltd?

What are the Net Income projections
for Polynovo Ltd?

How accurate were the past Net Income estimates
for Polynovo Ltd?

What are the EPS projections
for Polynovo Ltd?

How accurate were the past EPS estimates
for Polynovo Ltd?

What are the EBIT projections
for Polynovo Ltd?

How accurate were the past EBIT estimates
for Polynovo Ltd?

Compare the revenue forecasts
for Polynovo Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Polynovo Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Polynovo Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Polynovo Ltd compared to its peers.

Compare the P/E ratios
of Polynovo Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Polynovo Ltd with its peers.

Analyze the financial leverage
of Polynovo Ltd compared to its main competitors.

Show all profitability ratios
for Polynovo Ltd.

Provide ROE
for Polynovo Ltd.

Provide ROA
for Polynovo Ltd.

Provide ROIC
for Polynovo Ltd.

Provide ROCE
for Polynovo Ltd.

Provide Gross Margin
for Polynovo Ltd.

Provide Operating Margin
for Polynovo Ltd.

Provide Net Margin
for Polynovo Ltd.

Provide FCF Margin
for Polynovo Ltd.

Show all solvency ratios
for Polynovo Ltd.

Provide D/E Ratio
for Polynovo Ltd.

Provide D/A Ratio
for Polynovo Ltd.

Provide Interest Coverage Ratio
for Polynovo Ltd.

Provide Altman Z-Score Ratio
for Polynovo Ltd.

Provide Quick Ratio
for Polynovo Ltd.

Provide Current Ratio
for Polynovo Ltd.

Provide Cash Ratio
for Polynovo Ltd.

What is the historical Revenue growth
over the last 5 years for Polynovo Ltd?

What is the historical Net Income growth
over the last 5 years for Polynovo Ltd?

What is the current Free Cash Flow
of Polynovo Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Polynovo Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Polynovo Ltd

Current Assets 79.3m
Cash & Short-Term Investments 46m
Receivables 20.7m
Other Current Assets 12.6m
Non-Current Assets 29.4m
PP&E 24.2m
Intangibles 909k
Other Non-Current Assets 4.4m
Current Liabilities 23.2m
Accounts Payable 6.4m
Accrued Liabilities 2.2m
Short-Term Debt 815k
Other Current Liabilities 13.8m
Non-Current Liabilities 13.3m
Long-Term Debt 12.8m
Other Non-Current Liabilities 504k
Efficiency

Earnings Waterfall
Polynovo Ltd

Revenue
104.7m AUD
Cost of Revenue
-5.5m AUD
Gross Profit
99.2m AUD
Operating Expenses
-96.6m AUD
Operating Income
2.7m AUD
Other Expenses
2.6m AUD
Net Income
5.3m AUD

Free Cash Flow Analysis
Polynovo Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

PNV Profitability Score
Profitability Due Diligence

Polynovo Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROE is Increasing
ROIC is Increasing
48/100
Profitability
Score

Polynovo Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

PNV Solvency Score
Solvency Due Diligence

Polynovo Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
69/100
Solvency
Score

Polynovo Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PNV Price Targets Summary
Polynovo Ltd

Wall Street analysts forecast PNV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PNV is 2.82 AUD with a low forecast of 2.37 AUD and a high forecast of 3.15 AUD.

Lowest
Price Target
2.37 AUD
20% Upside
Average
Price Target
2.82 AUD
43% Upside
Highest
Price Target
3.15 AUD
59% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for PNV?

Click here to dive deeper.

Dividends

Polynovo Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for PNV is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

PNV Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Polynovo Ltd Logo
Polynovo Ltd

Country

Australia

Industry

Health Care

Market Cap

1.4B AUD

Dividend Yield

0%

Description

Polynovo Ltd. engages in the provision biodegradable medical devices. The company is headquartered in Melbourne, Victoria and currently employs 122 full-time employees. The Company’s principal activity is the development of medical devices for various applications. The Company’s products include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology. BTM is a man-made synthetic polymer that does not contain any biologic materials. BTM is a skin treatment. NovoSorb is a polymer, which is utilizes for the manufacture of novel medical devices, such as Biocompatible polymers. These biocompatible polymers are designed to support different functions of the body and then biodegrade into by-products that can be absorbed and excreted by the body. The company can be produced in a range of formats with different mechanical and degradation properties. In addition to NovoSorb BTM, they can be used for thermoplastic extrusions, filaments for weaving or knitting and as a solution for spray or dip coatings of other devices.

Contact

VICTORIA
Melbourne
U 2 320 Lorimer St
+61386814050.0
polynovo.com.au

IPO

1998-11-26

Employees

122

Officers

CEO & Director
Mr. Swami Raote BPHARM, M.B.A.
Chief Financial Officer
Mr. Jan-Marcel Gielen C.A.
Chief Technical & Scientific Officer
Dr. David McQuillan Ph.D.
Chief Information Officer
Mr. Philip Scorgie
Director of Operations
Mr. Ahmed Hassan
General Counsel & Company Secretary
Mr. Lior Harel
Show More
Chief People Officer
Ms. Ingrid Anderson
President of North America
Mr. Edward Graubart
Chief Medical Officer
Dr. Joseph F. Amaral M.D.
President of Asia Pacific
Mr. David N. Morris BAppSc, BBus
Show Less

See Also

Discover More
What is the Intrinsic Value of one PNV stock?

The intrinsic value of one PNV stock under the Base Case scenario is 0.81 AUD.

Is PNV stock undervalued or overvalued?

Compared to the current market price of 1.98 AUD, Polynovo Ltd is Overvalued by 59%.

Back to Top